{
  "ptid_time": "041_S_4143_2012-09-04",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4143/2012-09-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 45,659 mm³, 104.4% above the reference mean. With a Z-score of 2.61 (99.6th percentile), this represents significant enlargement; hippocampal volume measures 5,212 mm³, 32.2% below the reference mean. With a Z-score of -3.61 (0.0th percentile), this represents profound atrophy; whole brain volume measures 921,762 mm³, 10.4% below the reference mean. With a Z-score of -1.30 (9.7th percentile), this represents mild atrophy; entorhinal cortex volume measures 1,931 mm³, 50.4% below the reference mean. With a Z-score of -3.91 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 16,021 mm³, 12.0% below the reference mean. With a Z-score of -1.35 (8.8th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,558 mm³, 9.6% below the reference mean. With a Z-score of -0.85 (19.8th percentile), this represents normal volume . ",
  "text_data": "Age is 64.6 years. Gender is Female. Education: 19 years. MMSE: 29.0. MoCA: 23.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD), along with significant ventricular enlargement, suggesting neurodegeneration. However, cognitive scores (MMSE 29, MoCA 23) are only mildly impaired, with MoCA indicating possible subtle deficits. The absence of APOE4 reduces genetic risk but does not rule out AD.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype due to hippocampal/entorhinal atrophy).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration based on imaging, but MCI diagnosis is tentative due to near-normal MMSE and lack of detailed clinical history on functional decline).  \n\n*Note: A MoCA of 23/30 suggests mild cognitive dysfunction, but the MMSE (29/30) is less sensitive. Follow-up with neuropsychological testing (e.g., episodic memory assessments) and CSF/pet biomarkers would strengthen the diagnosis.*",
  "timestamp": "2025-07-26T07:13:50.557263"
}